ATM and neoplasm: The ATM-dependent DNA damage response pathway is frequently altered in NSCLC, with ATM mutations reported in approximately 9% of lung adenocarcinomas (LUAD) and 4% of squamous cell carcinomas, leading to genomic instability and enhanced tumor survival under genotoxic stress [49,50,51].